Integra Holdings is a healthcare investment company with an exclusive first right to examine the innovations and intellectual property emerging from the world-renowned Hebrew University of Jerusalem. With a focus on biopharmaceuticals and medical diagnostics and devices, Integra employs multidisciplinary teams of experts who work alongside inventors and take a hands-on approach to achieve commercial success.
Integra provides know-how and support to its portfolio companies from inception to commercialization, while leveraging its extensive industry network cultivated over decades of experience. The company holds a diversified portfolio of companies in the early to late stages, with established partnerships with investment funds such as OrbiMed, Pontifax, Lundbeck fund, SR One, CBI, and BioLight Life Sciences, as well as networks of private investors.
Integra Holdings was founded by Yissum, the technology transfer company of the Hebrew University of Jerusalem. Its shareholders include Yissum, Temasek, Invatech Holdings, Arie Capital, Guangxi Wuzhou Pharmaceutical Group Co Ltd, and Israeli Institutional funds, including the Israeli Teachers and Kindergarten Study funds, the Hebrew University Provident Fund, and Halman-Aldubi Investment Group.